Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

- 1 min read

ReNAgade Therapeutics Secures $300 Million Series A Funding to Revolutionize RNA Medicine

Cambridge, MA, May 23, 2023 (Business Wire) -- ReNAgade Therapeutics, a cutting-edge company focused on harnessing the full potential of RNA medicines for disease correction, has successfully raised $300 million in a Series A financing round led by MPM BioImpact and F2 Ventures. Built on innovative delivery technologies and an all-RNA platform, ReNAgade aims to overcome limitations in RNA therapeutics by expanding the reach of RNA medicines to previously inaccessible tissues and cells.

Read full article here.

Recent Posts

See All

Merck to Acquire Caraway Therapeutics for $610M

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Memo Therapeutics AG Appoints Erik van den Berg as CEO

Zürich, Switzerland, November 16, 2023 (Business Wire) -- Memo Therapeutics AG (“MTx”), a late-stage biotech firm advancing top-tier therapeutic antibodies, discloses the appointment of Erik van den

Boston Scientific Completes Acquisition of Relievant Medsystems, Inc.

Marlborough, MA, November 17, 2023 (PRNewswire) -- Boston Scientific Corporation (NYSE: BSX) announces the completion of its acquisition of Relievant Medsystems Inc., the sole provider of the FDA-cl

Merck to Acquire Caraway Therapeutics for $610M

Memo Therapeutics AG Appoints Erik van den Berg as CEO

Boston Scientific Completes Acquisition of Relievant Medsystems, Inc.

Teva names Richard Francis as CEO

BeiGene finalizes a $1.3B Agreement with Ensem for the CDK2 Inhibitor

Bristol Myers buys Orum's Blood Cancer Therapy for up to $180M

BioMarin Appoints Alexander Hardy President and CEO

Aiolos Bio Launches with $245M Series A

Cordis names Scott Drake as CEO

Inari Acquires LimFlow, a Limb-Saving Device Manufacturer, in a $415M Deal

Executive Spotlights

ReNAgade Therapeutics Secures $300 Million Series A Funding to Revolutionize RNA Medicine

Recent Posts

Life Science Headlines